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animals that are depleted of complement 
have a strongly reduced ability to mount 
an optimal acquired immune response to 
foreign antigens. Taken together comple-
ment acts as a rapid and efficient immune 
surveillance mechanism to control infection 
but also as an adjuvant for the induction 
of the acquired T- and B-cell response and 
ultimately in the generation of antibodies.. 
Once acquired immunity is operational 
the products of acquired immunity such 
as antibodies interact with complement 
and other components of innate immu-
nity and enhance protection against foreign 
pathogens.
There is also a downside to activation 
of the complement system as well. In the 
first place when tolerance against host tis-
sue and cells is broken and auto-antibodies 
are induced, the complement system may 
react with these auto-antibodies, increase 
tissue injury and amplify disease progres-
sion. Additionally complement has been 
shown to recognize altered self, a condition 
that may occur upon injury of host cells for 
instance during oxygen deprivation. Once 
these modified tissues are recognized by the 
complement initiating molecules proper-
din, C1q, MBL, or Ficolins, other mediator 
systems like pentraxins may amplify com-
plement activation and aggravate tissue 
injury. In general host cells are protected 
from complement-mediated injury by 
membrane bound regulators of comple-
ment activation. During tissue injury the 
expression of these regulator molecules may 
be reduced resulting in reduced protection 
of cells and tissue so that increased tissue 
damage can take place.
Recent studies have indicated that the 
balance between complement activation 
and control of activation is a delicate one. 
In cases where the turnover (activation) of 
C3 is enhanced, either in the circulation or 
at the tissue level, disease may take place as 
has been shown in patients with atypical 
hemolytic uremic syndrome, age related 
macular degeneration, and membranopro-
liferative glomerulonephritis. Therefore it 
( dendritic cells). Upon entrance of patho-
gens almost instant recognition of the path-
ogens occurs by cellular and soluble pattern 
like recognition molecules. Concerning 
complement – mediated recognition, espe-
cially the recognition molecules like C1q, 
properdin, mannan binding lection, and 
Ficolins, play an important role.
Once recognition of a pathogen has 
occurred, complement activation and sub-
sequent deposition of activated comple-
ment fragments, such as C3b, takes place on 
the membrane of the pathogen which result 
in two major events. In the first place further 
activation of complement results in the gen-
eration of the membrane attack complex 
of complement and subsequent cytolysis. 
The other major function of complement 
activation is that pathogens opsonized 
with C3b or other breakdown fragments 
of C3 lead to engagement of cellular C3 
receptors on many cells like macrophages, 
granulocytes, T-cells, B-cells, and antigen 
presenting cells. These interactions in the 
first place result in efficient elimination of 
foreign pathogens and additionally serve to 
present antigens in an optimal fashion, via 
cellular complement receptors, to antigen 
presenting cells and finally to the activa-
tion of T- and B-cells and induction of the 
acquired immune response. In this regard 
it is known for a long time that for instance 
More than 95% of living organisms on the 
world protect themselves from infectious 
challenges using their innate immune sys-
tem. The others protect themselves both 
by innate- and acquired mechanisms. The 
acquired immune system has been studied 
extensively and remains a focus for intensive 
investigation for the coming period. On the 
other hand there has also been a long his-
tory of investigation of certain components 
of innate immunity like the Toll and the 
complement system. These days we know 
that hosts like humans are optimally pro-
tected against pathogenic stress when both 
the innate and acquired immune systems 
are intact and functional.
In case of deficiencies or abnormalities 
in acquired immunity, like defective func-
tion of T- or B-cells and malfunction of 
innate immunity, like complement deficien-
cies, major disturbance of host protection 
may occur.
Several soluble and cellular mediator sys-
tems comprise innate immunity (Figure).
The soluble mediator systems amongst 
others are: cytokines, chemokines, 
defensins, pentraxins, the complement sys-
tem, and presumably other, yet to define, 
mediator systems. The cellular components 
of innate immunity consist, amongst oth-
ers, of NK cells, macrophages, granulocytes, 
eosinophils, and antigen presenting cells 
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repair. Definition of the imbalance in 
local “homeostasis” in combination 
with complement abnormalities will 
be essential for the understanding of 
the molecular basis of several diseases 
where hyper catabolism of C3 takes 
place. In this regard the discovery and 
clinical implementation of innovative 
drugs and new biological reagents, to 
either attenuate or enhance comple-
ment activation, in specific diseases is 
essential.
These demanding objectives can only be 
reached through concerted efforts of clini-
cians and basic researchers.
A major challenge remains the transla-
tion of clinical observations to well defined 
research projects that can lead the way from 
basic discoveries to clinical implementation.
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the major production site of comple-
ment components is the liver, however 
quite a number of complement compo-
nents like properdin, C1q, and C7 are 
produced at extra hepatic sites as well. 
The contribution of local complement 
production and control by other tissues 
than the liver and their contribution to 
local defense and inflammation requi-
res major attention.
•	 Control	of	innate	and	adaptive	immu-
nity: the cross-talk between innate 
immune players and products of acqui-
red immunity in shaping an optimal 
defense against known and future 
infective challenges requires major 
attention. In this regard the use of the 
“adjuvant capacity” of complement to 
enhance the induction of the acquired 
immune response has to be exploi-
ted more optimally for the design of 
novel strategies and the development 
of next generation vaccines for known 
and yet to discover viral and bacterial 
organisms.
•	 Translational	 research:	 the	 generation	
of animals with deficiencies of several 
complement components and regu-
lators has revealed that complement 
is not only involved in host defense 
but that it is a major player in tissue 
seems essential to devise specific comple-
ment inhibiting therapies that can be used 
for the treatment of complement-mediated 
injuries.
The below bullet point comments give 
some examples of the big challenges faced 
by clinicians and basic scientists for the near 
future:
•	 Complement	 and	 complement	 recep-
tor cross-talk: although major advance 
has been achieved in this field, like elu-
cidation of the crystal structure of C3, 
major challenges lie ahead to define the 
many cellular receptor interactions and 
subsequent functions of several com-
plement receptors.
•	 Induction	 of	 the	 acquired	 immune	
response: here the role of the several 
soluble mediator systems and their 
function in the initial recognition and 
presentation of antigens, via specific 
cellular receptors, to antigen presenting 
cells and T- and B-cells requires further 
major innovative approaches and fine-
tuning. In this regard the cross-talk 
with toll like receptors has just started 
to be elucidated.
•	 How	 do	 chemokines	 and	 cytokines	
control the local production and fun-
ction of complement: it is known that 
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